The allegations made by a former DEA agent against his own agency are sending shockwaves across the United States and casting a dark shadow over the nation's efforts to combat the fentanyl crisis. According to whistleblower testimony, US Drug Enforcement Agency (DEA) agents allegedly allowed hundreds of thousands of fentanyl pills to be trafficked into New Mexico, a state severely affected by opioid addiction. The explosive claims, first reported by the Associated Press, suggest that agents permitted large quantities of the highly addictive and deadly substance to flood Albuquerque in order to secure larger drug-trafficking busts.
Former DEA special agent David Howell stated, "We poisoned our community to make cases," alleging that the agency possessed detailed intelligence regarding drug deliveries, including precise pill counts for shipments destined for Albuquerque. He claimed to have witnessed instances where agents observed transactions, such as 74,000 fentanyl pills at an Albuquerque mobile home park in June 2023, without intervening. Howell's allegations have sparked intense scrutiny of the DEA's strategy in combating the fentanyl crisis.
The DEA has rejected the allegations, stating that public descriptions suggesting the agency knowingly allowed fentanyl to reach communities are "false and fundamentally mischaracterise the facts." The agency clarified that the cases in question involved "complex, court-authorised Title III investigations" where agents and prosecutors conducted real-time surveillance and intelligence gathering to target larger drug trafficking organisations. They asserted that all operational decisions were made in coordination with US Attorney offices and were "lawful, reasonable under the circumstances, and consistent with department guidance."
Despite the DEA's denial, the controversy has prompted New Mexico Attorney General Raúl Torrez to announce a formal investigation into the allegations. In a letter to Governor Michelle Lujan Grisham, Torrez stated that if the allegations are accurate, "the consequences for New Mexicans were not abstract. They were fatal." The state already struggles with a high rate of fentanyl overdose deaths, and Torrez has pledged to pursue all legal avenues for accountability, while acknowledging the constitutional protections for federal employees acting within their authority.
The implications of these allegations are far-reaching, raising questions about the DEA's priorities in combating the fentanyl crisis. While some regions in the US have seen a decline in drug fatalities, New Mexico has not experienced this downward trend, making the allegations particularly poignant for the affected communities.